Uroplasty Inc was incorporated on January 21, 1992 as a Minnesota corporation. It is a medical device company. It develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Its primary focus is on two products: the Urgent PC Neuromodulation System, and Macroplastique Implants. The Urgent PC Neuromodulation System delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The Macroplastique Implants is an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. The Company is focusing its sales and marketing efforts primarily on urologists, urogynecologists and gynecologists with significant office-based and outpatient surgery-based patient volume. The testing, manufacturing, promotion, marketing and distribution of the Company's products in the United States, Europe and other parts of the world are subject to regulation by numerous governmental authorities, including the FDA, the European Union and other analogous agencies.